Recombinant adenovirus-poxvirus prime-boost malaria vaccine (University of Oxford)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant adenovirus-poxvirus prime-boost malaria vaccine (University of Oxford)

Drug Alias NameAdCh63-AMA1

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionApical membrane antigen 1 modulators

TargetsApical membrane antigen 1

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Oxford

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Oxford

Active IndicationsN/A

Inactive IndicationsMalaria

Other Information

ATC CodeN/A